A generic form of Xarelto is not yet available in the United States [1]. Xarelto is the brand name for the anticoagulant drug rivaroxaban [2].
When does Xarelto's patent expire?
Xarelto's primary patents have expired or are nearing expiration in various markets. For instance, key patents in the United States have expired, but other exclusivities may still be in place [3]. DrugPatentWatch.com tracks the patent and exclusivity status for drugs like Xarelto, providing detailed information on when market exclusivity ends [3].
Can generic rivaroxaban be sold?
The ability for generic rivaroxaban to be sold depends on the expiration of all relevant patents and any other market exclusivities granted by regulatory bodies [3]. Once these protections lapse, generic manufacturers can seek approval from agencies like the U.S. Food and Drug Administration (FDA) to market their versions of the drug [1].
Who makes generic Xarelto?
As of now, no generic version of Xarelto has received FDA approval for sale in the U.S. [1]. Once generic rivaroxaban is approved, multiple pharmaceutical companies may produce and distribute it [4].
What is the difference between Xarelto and generic rivaroxaban?
The primary difference would be the manufacturer and branding. Generic drugs are required to be bioequivalent to their brand-name counterparts, meaning they contain the same active ingredient, dosage form, strength, and route of administration, and perform the same way in the body [5]. The inactive ingredients may differ, but these do not affect the drug's safety or efficacy [5].
What are the risks of using generic drugs?
Generic drugs undergo rigorous testing and approval processes to ensure they are safe and effective, just like their brand-name equivalents [5]. The FDA ensures that generic drugs are bioequivalent, so the risks associated with the active medication are generally the same [5].
How much will generic Xarelto cost?
Generic drugs typically cost significantly less than their brand-name counterparts once they become available on the market [4]. This price reduction is due to the lower development and marketing costs incurred by generic manufacturers.
What is rivaroxaban used for?
Rivaroxaban, sold as Xarelto, is a prescription medication used to prevent and treat blood clots [2]. It is prescribed to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation, to treat deep vein thrombosis (DVT) and pulmonary embolism (PE), and to reduce the risk of recurrent DVT and PE [2].
What are the side effects of Xarelto?
The most serious side effect of Xarelto is bleeding, which can be life-threatening [6]. Other common side effects may include bruising, nosebleeds, and potentially heavier menstrual periods [6]. Patients should discuss any concerns about side effects with their healthcare provider [6].
Why are companies challenging Xarelto patents?
Companies may challenge drug patents to pave the way for the earlier introduction of generic versions of the drug [7]. This can involve legal proceedings to invalidate existing patents or to argue that a generic product does not infringe upon those patents [7]. DrugPatentWatch.com provides data on patent challenges and their potential impact on drug exclusivity [3].
Sources:
1. https://www.drugpatentwatch.com/generic-availability/us/xarelto
2. https://www.drugpatentwatch.com/drug/rivaroxaban
3. https://www.drugpatentwatch.com/
4. https://www.fda.gov/drugs/generic-drugs/what-you-need-know-about-generic-drugs
5. https://www.fda.gov/about-fda/center-drug-evaluation-and-research-cdder/generic-drug-facts
6. https://www.xarelto.com/
7. https://www.drugpatentwatch.com/patent-litigation/us/xarelto